Registry of patients with high lipoprotein(a) levels
Official title: The Prevalence, Patients' Characteristics, and Hyper-Lp(a)-Emia Risk Factors in the Polish Population. The Polish Mother's Memorial Hospital Research Institute Lipoprotein(a) Registry
Run by Polish Mother Memorial Hospital Research Institute · NCT06610669 · Data updated 2026-11-12
This study is collecting information from patients with high lipoprotein(a) levels to better understand how it affects their health and what other conditions they might have.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Polish Mother Memorial Hospital Research Institute Academic / other |
| Locations | 1 site (Lodz) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | January 2028 |
| Study ends | June 2028 |
| Registry record updated | September 24, 2024 |
| Trial ID | NCT06610669 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are patients who have had their lipoprotein(a) levels measured and are receiving care in the relevant departments.
✕Probably not a fit
Patients who have not had their lipoprotein(a) levels measured or do not have relevant cardiovascular or endocrine conditions may not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PMMHRI-Lp(a)-Registry is a non-interventional, observational registry that collects data on patients with measured lipoprotein(a) concentrations at the Polish Mother's Memorial Hospital Research Institute. Established in January 2022, it includes patients from the Departments of Cardiology and Endocrinology, focusing on those with elevated Lp(a) levels as per the latest Polish guidelines. The registry gathers comprehensive patient information, including demographics, comorbidities, medications, and cardiovascular risk scores, to better understand the prevalence and implications of hyper-Lp(a)-emia.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of hyper-Lp(a)-emia and improve management strategies for affected patients.
How similar studies have gone: While this registry approach is not novel, it builds on existing knowledge and practices in the field of lipid management, potentially contributing valuable data to ongoing discussions about hyper-Lp(a)-emia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * measured lipoprotein(a) concentration Exclusion Criteria: \-
Where it's running
-
Polish Mother Memorial Research Institute
Lodz, Poland Recruiting
Study contacts
- Study coordinator: Maciej Banach, MD,PhD,FNLA,FAHA,FESC,FASA
- Email: maciej.banach@icloud.com
- Phone: +48 42 2711599
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.